SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-002061
Filing Date
2017-01-26
Accepted
2017-01-26 20:02:41
Documents
1
Period of Report
2017-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4130
  Complete submission text file 0000899243-17-002061.txt   5807
Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840
Jounce Therapeutics, Inc. (Issuer) CIK: 0001640455 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ELIAN FIDUCIARY SERVICES (CAYMAN) LTD 89 NEXUS WAY, CAMANA BAY GRAND CAYMAN E9 KY1-9007
Business Address ELIAN FIDUCIARY SERVICES (CAYMAN) LTD 89 NEXUS WAY, CAMANA BAY GRAND CAYMAN E9 KY1-9007 617-790-7163
Hadley Harbor Master Investors (Cayman) L.P. (Reporting) CIK: 0001641080 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37998 | Film No.: 17551396